1.Increasing the alpha 2, 6 Sialylation of Glycoproteins May Contribute to Metastatic Spread and Therapeutic Resistance in Colorectal Cancer.
Gut and Liver 2013;7(6):629-641
Abnormal glycosylation due to dysregulated glycosyltransferases and glycosidases is a key phenomenon of many malignancies, including colorectal cancer (CRC). In particular, increased ST6 Gal I (beta-galactoside alpha 2, 6 sialyltransferase) and subsequently elevated levels of cell-surface alpha 2, 6-linked sialic acids have been associated with metastasis and therapeutic failure in CRC. As many CRC patients experience metastasis to the liver or lung and fail to respond to curative therapies, intensive research efforts have sought to identify the molecular changes underlying CRC metastasis. ST6 Gal I has been shown to facilitate CRC metastasis, and we believe that additional investigations into the involvement of ST6 Gal I in CRC could facilitate the development of new diagnostic and therapeutic targets. This review summarizes how ST6 Gal I has been implicated in the altered expression of sialylated glycoproteins, which have been linked to CRC metastasis, radioresistance, and chemoresistance.
Antigens, CD/*metabolism
;
Colorectal Neoplasms/*metabolism/pathology/*therapy
;
Drug Resistance, Neoplasm
;
Glycoproteins/*metabolism
;
Humans
;
Liver Neoplasms/secondary
;
Lung Neoplasms/secondary
;
Radiation Tolerance
;
Receptor, Epidermal Growth Factor/metabolism
;
Sialic Acids/*metabolism
;
Sialyltransferases/*metabolism
2.Association between Parental Cotinineverified Smoking Status and Childhood Asthma: a Population-based Nationally Representative Analysis
Jinho JUNG ; Hyun Joon PARK ; Minyoung JUNG
Journal of Korean Medical Science 2021;36(30):e193-
Background:
Environmental tobacco smoke exposure due to parents is a modifiable risk factor for childhood asthma, but many studies have evaluated parental smoking using selfreported data. Therefore, we aimed to analyze the relationship between parental cotinineverified smoking status and asthma in their children.
Methods:
This population-based cross-sectional study used data from the Korean National Health and Nutrition Examination Survey from 2014 to 2017. Participants aged 0 to 18 years with complete self-reported physician-diagnosed childhood asthma and measurement of their parental urinary cotinine levels were included. Parental urinary cotinine-verified smoking status was defined using both urinary cotinine levels and self-report, as active, passive, and non-smoker. Sample weights were applied to all statistical analyses because of a complex, multistage and clustered survey design. Logistic regression model was used to analyze the relationship between childhood asthma and parental smoking.
Results:
A total of 5,264 subjects aged < 19 years were included. The prevalence of asthma was 3.4%. The proportions of paternal and maternal urinary cotinine-verified active smokers during the study period were 50.4% and 16.9%, respectively. When parental urinary cotinine level increased, the proportion of parental low household income was increased (P < 0.001).There was no significant association between the parental urinary cotinine-verified smoking group and childhood asthma group. However, the adjusted odds ratios of childhood asthma in the middle and highest tertile of paternal urinary cotinine levels compared with those in lowest tertile were 1.95 (95% confidence interval [CI], 0.98–3.89) and 2.34 (95% CI, 1.21–4.54), respectively.
Conclusion
There seems to be a dose-related association between paternal urinary cotinine levels and the risk of childhood asthma. Because of the high rate of paternal smoking, further studies are needed to develop a targeted strategy to reduce parental smoking for childhood asthma.
3.Association between Parental Cotinineverified Smoking Status and Childhood Asthma: a Population-based Nationally Representative Analysis
Jinho JUNG ; Hyun Joon PARK ; Minyoung JUNG
Journal of Korean Medical Science 2021;36(30):e193-
Background:
Environmental tobacco smoke exposure due to parents is a modifiable risk factor for childhood asthma, but many studies have evaluated parental smoking using selfreported data. Therefore, we aimed to analyze the relationship between parental cotinineverified smoking status and asthma in their children.
Methods:
This population-based cross-sectional study used data from the Korean National Health and Nutrition Examination Survey from 2014 to 2017. Participants aged 0 to 18 years with complete self-reported physician-diagnosed childhood asthma and measurement of their parental urinary cotinine levels were included. Parental urinary cotinine-verified smoking status was defined using both urinary cotinine levels and self-report, as active, passive, and non-smoker. Sample weights were applied to all statistical analyses because of a complex, multistage and clustered survey design. Logistic regression model was used to analyze the relationship between childhood asthma and parental smoking.
Results:
A total of 5,264 subjects aged < 19 years were included. The prevalence of asthma was 3.4%. The proportions of paternal and maternal urinary cotinine-verified active smokers during the study period were 50.4% and 16.9%, respectively. When parental urinary cotinine level increased, the proportion of parental low household income was increased (P < 0.001).There was no significant association between the parental urinary cotinine-verified smoking group and childhood asthma group. However, the adjusted odds ratios of childhood asthma in the middle and highest tertile of paternal urinary cotinine levels compared with those in lowest tertile were 1.95 (95% confidence interval [CI], 0.98–3.89) and 2.34 (95% CI, 1.21–4.54), respectively.
Conclusion
There seems to be a dose-related association between paternal urinary cotinine levels and the risk of childhood asthma. Because of the high rate of paternal smoking, further studies are needed to develop a targeted strategy to reduce parental smoking for childhood asthma.
4.Erratum: A Retrospective Analysis of Use in Hospitalized Children with Upper Respiratory Tract Infection.
Minyoung JUNG ; Ji Hyun PARK ; Chi Eun OH
Pediatric Infection & Vaccine 2017;24(3):193-193
The authors found an error in the title. Th etitle has been updated from “A Retrospective Analysis of Use in Hospitalized Children with Upper Respiratory Tract Infection” to “A Retrospective Analysis of Antibiotic Use in Hospitalized Children with Upper Respiratory Tract Infection.”
Child
;
Child, Hospitalized*
;
Humans
;
Respiratory System*
;
Respiratory Tract Infections*
;
Retrospective Studies*
5.Erratum: A Retrospective Analysis of Use in Hospitalized Children with Upper Respiratory Tract Infection.
Minyoung JUNG ; Ji Hyun PARK ; Chi Eun OH
Pediatric Infection & Vaccine 2017;24(3):193-193
The authors found an error in the title. Th etitle has been updated from “A Retrospective Analysis of Use in Hospitalized Children with Upper Respiratory Tract Infection” to “A Retrospective Analysis of Antibiotic Use in Hospitalized Children with Upper Respiratory Tract Infection.”
Child
;
Child, Hospitalized*
;
Humans
;
Respiratory System*
;
Respiratory Tract Infections*
;
Retrospective Studies*
6.A Retrospective Analysis of Use in Hospitalized Children with Upper Respiratory Tract Infection.
Minyoung JUNG ; Ji Hyun PARK ; Chi Eun OH
Pediatric Infection & Vaccine 2017;24(2):87-94
PURPOSE: The inappropriate prescription of antibiotics in children with upper respiratory tract infection (URTI) is common. This study evaluated the factors that influence antibiotics use in hospitalized children with viral URTI confirmed by reverse transcriptase-polymerase chain reaction (RT-PCR)assay. METHODS: The medical records of admitted patients who performed RT-PCR assay for respiratory virus pathogens from January 2013 to November 2014 were examined. The demographic and clinical features were compared between patients who were administered antibiotics at admission and those who were not. We also investigated differences between children who continued antibiotics and those who stopped antibiotics after a viral pathogen was identified. RESULTS: In the total 393 inpatients, the median age was 23 months (interquartile range, 13 to 41.3 months). Antimicrobial agents were prescribed in 79 patients (20.1%) at admission. Patients with acute otitis media (AOM) had higher rates of antibiotics prescription than those without AOM (48.1% vs. 2.2%, P <0.001), with an adjusted odds ratio of 91.1 (95% confidence interval, 30.5 to 271.7). Level of high-sensitivity C-reactive protein and the proportion of acute rhinosinusitis were also significantly associated with antibiotics use (P <0.001). Among the 44 patients with viruses identified using the RT-PCR method during hospitalization, antibiotic use was continued in 28 patients (63.6%). AOM was statistically associated with continued antibiotic use in the patients (P =0.002). CONCLUSIONS: Although the respiratory virus responsible for URTI etiology is identified, clinicians might not discontinue antibiotics if AOM is accompanying. Therefore, careful diagnosis and management of AOM could be a strategy to reduce unjustified antibiotic prescriptions for children with URTI.
Anti-Bacterial Agents
;
Anti-Infective Agents
;
C-Reactive Protein
;
Child
;
Child, Hospitalized*
;
Diagnosis
;
Hospitalization
;
Humans
;
Inappropriate Prescribing
;
Inpatients
;
Medical Records
;
Methods
;
Odds Ratio
;
Otitis Media
;
Polymerase Chain Reaction
;
Prescriptions
;
Respiratory System*
;
Respiratory Tract Infections*
;
Retrospective Studies*
7.The Effect of Rhus verniciflua Stokes Extracts on Photo-Aged Mouse Skin.
Hannah HONG ; Minyoung JUNG ; Sung Jay CHOE ; Jung Bae KIM ; Eung Ho CHOI
Annals of Dermatology 2017;29(3):295-301
BACKGROUND: Rhus verniciflua Stokes (RV) has traditionally been used in Korea as an indigenous food (Rhus chicken soup) and as an herbal medicinal plant. While the anticancer, antimicrobial, and anti-inflammatory properties of RV have been actively studied in the medical field, its antioxidant effects in the skin that resist the reactive oxygen species in keratinocytes and fibroblasts is less understood. OBJECTIVE: We designed to evaluate the effects of R. verniciflua Stokes extract (RVE) on the photo-aged skin by an in vitro experiment using human fibroblasts and an in vivo experiment using a photo-aged murine model. METHODS: For the in vitro experiments, human fibroblasts irradiated with ultraviolet (UV) B were treated with RVE or vehicle, and the growth levels and the expression level of type 1 procollagen were compared. For the in vivo experiment, photo-aged mice irradiated with UVB and UVA were administered drinking water with or without RVE, and histological changes and the expression level of type 1 procollagen and matrix metalloprotease (MMP)-13 were compared. RESULTS: In vitro experiments using fibroblasts irradiated with UVB showed that RVE promoted growth and significantly increased the expression of type 1 procollagen as compared to the control group. In the photo-aged mice, RVE increased collagen content in the dermis and promoted the synthesis of type 1 procollagen without any visible decrease in MMP-13 as compared to control group. CONCLUSION: In addition to the previously reported antioxidant effects of RVE, oral intake of RVE effectively inhibited photo-aging in hairless mice by enhancing collagen synthesis.
Aging
;
Animals
;
Antioxidants
;
Chickens
;
Collagen
;
Dermis
;
Drinking Water
;
Fibroblasts
;
Humans
;
In Vitro Techniques
;
Keratinocytes
;
Korea
;
Mice*
;
Mice, Hairless
;
Plants, Medicinal
;
Procollagen
;
Reactive Oxygen Species
;
Rhus*
;
Skin*
8.Dermal Proliferative Effect and Safety of Automicroneedle Therapy System (AMTS).
Jae Hong KIM ; Hwa Young PARK ; Minyoung JUNG ; Eung Ho CHOI
Korean Journal of Dermatology 2010;48(11):955-965
BACKGROUND: Various topical cosmeceuticals and lasers have been used to treat photo-aged skin that has wrinkles, acne scars and dilated pores. The microneedle therapy system (MTS) that mechanically makes multiple holes on the skin has come into the limelight to treat these skin problems via stimulating collagen remodeling. The automicroneedle therapy system (AMTS) is a developed version of MTS and it has several advantages compared with conventional MTS. AMTS can achieve regular treatment results because of its automatically punching method. In addition, AMTS can treat smaller area and it has cost advantages due to the inexpensive disposable needle head. OBJECTIVE: This study was designed to determine the dermal proliferative effects and safety of AMTS on the skin compared with that of the conventional MTS roller. METHODS: Twelve hairless mice were divided into two groups; one group was treated with a 0.25 mm needle and the other group was treated with a 2 mm needle. The first group was subdivided into the AMTS-H and the MTS groups and the no treatment group as a control, while the second group was subdivided into the AMTS-H, AMTS, MTS and control groups. Each treated group underwent four procedures every other day. The dermal proliferative efficacies of the treatment were evaluated by the histology, including the dermal thickness and the densities of the collagen fibers. Western blot was also performed for the evaluation of the protein expression of procollagen type I and matrix metalloproteinase-13. For safety profiles, we performed gross observation, basal skin barrier function testing and histologic examination. RESULTS: Treatment by AMTS significantly increased dermal collagen synthesis and the dermal thickness in the hairless mice. In addition, the expression of procollagen type I protein was increased, which accounted for the increased dermal collagen density. There was no specific safety problem related to the treatment. CONCLUSION: These results indicated that AMTS is an effective, safe modality for treating skin problems that require dermal proliferation. We anticipate that AMTS could be a new therapeutic option for inducing dermal proliferation or regeneration.
Acne Vulgaris
;
Animals
;
Blotting, Western
;
Cicatrix
;
Collagen
;
Collagen Type I
;
Head
;
Matrix Metalloproteinase 13
;
Mice
;
Mice, Hairless
;
Needles
;
Regeneration
;
Skin
9.Validation of the Pediatric Index of Mortality 3 in a Single Pediatric Intensive Care Unit in Korea.
Ok Jeong LEE ; Minyoung JUNG ; Minji KIM ; Hae Kyoung YANG ; Joongbum CHO
Journal of Korean Medical Science 2017;32(2):365-370
To compare mortality rate, the adjustment of case-mix variables is needed. The Pediatric Index of Mortality (PIM) 3 score is a widely used case-mix adjustment system of a pediatric intensive care unit (ICU), but there has been no validation study of it in Korea. We aim to validate the PIM3 in a Korean pediatric ICU, and extend the validation of the score from those aged 0–16 to 0–18 years, as patients aged 16–18 years are admitted to pediatric ICU in Korea. A retrospective cohort study of 1,710 patients was conducted in a tertiary pediatric ICU. To validate the score, the discriminatory power was assessed by calculating the area under the receiver-operating characteristic (ROC) curve, and calibration was evaluated by the Hosmer-Lemeshow goodness-of-fit (GOF) test. The observed mortality rate was 8.47%, and the predicted mortality rate was 6.57%. For patients aged < 18 years, the discrimination was acceptable (c-index = 0.76) and the calibration was good, with a χ² of 9.4 in the GOF test (P = 0.313). The observed mortality rate in the hemato-oncological subgroup was high (18.73%), as compared to the predicted mortality rate (7.13%), and the discrimination was unacceptable (c-index = 0.66). In conclusion, the PIM3 performed well in a Korean pediatric ICU. However, the application of the PIM3 to a hemato-oncological subgroup needs to be cautioned. Further studies on the performance of PIM3 in pediatric patients in adult ICUs and pediatric ICUs of primary and secondary hospitals are needed.
Adult
;
Benchmarking
;
Calibration
;
Child
;
Cohort Studies
;
Critical Care*
;
Discrimination (Psychology)
;
Humans
;
Intensive Care Units*
;
Korea*
;
Mortality*
;
Retrospective Studies
;
Risk Adjustment
10.Immunodetections of the Metalloproteinase (MMP-2 and MMP-9) and Tissue Inhibitor of Metalloproteinases (TIMP-2) in Prostatic Adenocarcinomas.
Sung Sook KIM ; Yeong Ju WOO ; Jooryung HUH ; Heesoo YOON ; Jung Mi PARK ; Minyoung KIM
Journal of the Korean Cancer Association 1997;29(3):445-453
PURPOSE: The metalloproteinases (MMP) and their inhibitors (TIMP) have been suggested to play a role in tumor invasion and metastasis. There have been some dispute on the exact role of TIMP and MMP in tumor progression. The purpose of this study is to prove TIMP expression in relation with prevention of tumor progression including invasion or metastasis with MMP expression. MATERIALS AND METHODS: We have performed immunohistochemical staining of MMP-2, MMP-9 and TIMP-2 on 15 cases of benign prostatic hyperoplasia (BPH), and 30 cases of prostatic carcinomas which were classified as angio or neural invasion positive (PC-2) and negative group (PC-1). RESULTS: MMP-2, MMP-9, and TIMP-2 were not detected in BPH. PC-2 pateints had higher levels of collagenases than BPH, while PC-1 patients had higher levels of TIMP-2 and lower levels of MMP-2, MMP-9 than PC-2. Expression of TIMP-2 were inversely proportional to collagenases. CONCLUSION: We conclude that highly invasive prostatic carcinoma (PC-2) contained relatively high levels of MMP-2, MMP-9 and low amounts of TIMP-2. These results are discussed with respect to the possible role of MMPs and TIMP in prostatic tumor progression.
Adenocarcinoma*
;
Collagenases
;
Dissent and Disputes
;
Humans
;
Matrix Metalloproteinases
;
Metalloproteases
;
Neoplasm Metastasis
;
Tissue Inhibitor of Metalloproteinase-2
;
Tissue Inhibitor of Metalloproteinases*